T1661 | Crizotinib | 877399-52-5 | 450.34 | 10mM | ALK; Autophagy; c-Met/HGFR; ROS; ROS Kinase |
T1726 | SB-431542 | 301836-41-9 | 384.39 | 10mM | ALK; TGF-beta/Smad |
T1763 | SB 525334 | 356559-20-1 | 343.42 | 10mM | ALK; TGF-beta/Smad |
T1791 | Ceritinib | 1032900-25-6 | 558.14 | 10mM | ALK; IGF-1R; Serine Protease |
T1800 | GW788388 | 452342-67-5 | 425.48 | 10mM | ALK; TGF-beta/Smad |
T1900 | LDN-212854 | 1432597-26-6 | 406.48 | 10mM | ALK; TGF-beta/Smad |
T1914 | K02288 | 1431985-92-0 | 352.38 | 10mM | ALK; TGF-beta/Smad |
T1936 | Alectinib | 1256580-46-7 | 482.62 | 10mM | ALK; Tyrosine Kinases; VEGFR |
T1942 | DMH-1 | 1206711-16-1 | 380.44 | 10mM | ALK; Autophagy; TGF-beta/Smad |
T1943 | ML347 | 1062368-49-3 | 352.39 | 10mM | ALK; TGF-beta/Smad |
T1944 | LDN-214117 | 1627503-67-6 | 419.52 | 10mM | ALK; TGF-beta/Smad |
T1962 | ASP3026 | 1097917-15-1 | 580.74 | 10mM | ALK; Apoptosis |
T1967 | AZD-3463 | 1356962-20-3 | 448.95 | 10mM | ALK; Apoptosis; Autophagy; IGF-1R |
T2098 | A 77-01 | 607737-87-1 | 286.33 | 10mM | ALK; TGF-beta/Smad |
T2251 | NVP-TAE 684 | 761439-42-3 | 614.2 | 10mM | ALK; Apoptosis |
T2449 | D4476 | 301836-43-1 | 398.41 | 10mM | ALK; Apoptosis; Autophagy; Casein Kinase |
T2462 | SB-505124 | 694433-59-5 | 335.4 | 10mM | ALK; TGF-beta/Smad |
T2641 | KRCA-0008 | 1472795-20-2 | 609.12 | 10mM | ACK; ALK |
T2655 | CEP-37440 | 1391712-60-9 | 580.12 | 10mM | ALK; FAK |
T3031 | A 83-01 | 909910-43-6 | 421.52 | 10mM | ALK; TGF-beta/Smad |
T3041 | ALK inhibitor 2 | 761438-38-4 | 518.03 | 10mM | ALK; FAK |
T3059 | ALK-IN-1 | 1197958-12-5 | 529.01 | 10mM | ALK; EGFR; IGF-1R |
T3061 | Lorlatinib | 1454846-35-5 | 406.41 | 10mM | ALK; Apoptosis; ROS; Tyrosine Kinases; ROS Kinase |
T3550 | X-376 | 1365267-27-1 | 547.41 | 10mM | ALK; c-Met/HGFR |
T3678 | Entrectinib | 1108743-60-7 | 560.64 | 10mM | ALK; Autophagy; ROS; Trk receptor; ROS Kinase |
T4015 | HG-14-10-04 | 1356962-34-9 | 532.08 | 10mM | ALK |
T4071 | Repotrectinib | 1802220-02-5 | 355.37 | 10mM | ALK; ROS; Src; Trk receptor; ROS Kinase |
T4257 | Belizatinib | 1357920-84-3 | 577.75 | 10mM | ALK; Trk receptor |
T6158 | LDN-193189 HCl | 1062368-62-0 | 442.94 | 10mM | ALK |
T6337 | RepSox | 446859-33-2 | 287.32 | 10mM | ALK; TGF-beta/Smad |
T6496 | Vactosertib | 1352608-82-2 | 399.42 | 10mM | ALK; TGF-beta/Smad |
T4975 | SM 16 | 614749-78-9 | 430.5 | 10mM | ALK; TGF-beta/Smad |
T5197 | BIBF0775 | 334951-90-5 | 494.64 | 10mM | ALK; TGF-beta/Smad |
T8108 | Blu-782 | 2141955-96-4 | 562.7 | 10mM | ALK |
T8399 | Crizotinib hydrochloride | 1415560-69-8 | 486.8 | 10mM | ALK; Autophagy; c-Met/HGFR; ROS; ROS Kinase |
T16708 | R-268712 | 879487-87-3 | 363.39 | 10mM | ALK; TGF-beta/Smad |
T1791L | Ceritinib dihydrochloride | 1380575-43-8 | 631.06 | 10mM | ALK; IGF-1R |
T10759 | CEP-28122 mesylate salt (1022958-60-6 free base) | T10759 | 635.17 | 10mM | ALK |
T9224 | CH5424802 analog | 1256577-71-5 | 454.56 | 10mM | ALK |
T13564 | AZ7550 | 1421373-99-0 | 485.58 | 10mM | ACK; ALK; BTK; Drug Metabolite; EGFR; FAK; FLT; IGF-1R; MLK; MNK; PYK2; Tyrosine Kinases |
T22324 | Ensartinib hydrochloride | 2137030-98-7 | 634.36 | 10mM | ALK; c-Met/HGFR; Trk receptor |
T10285 | ALK inhibitor 1 | 761436-81-1 | 562.48 | 10mM | ALK; FAK; IGF-1R |
T11254 | F-1 | 2244775-31-1 | 519.02 | 10mM | ALK; ROS; ROS Kinase |
T13416 | ZX-29 | 2254805-62-2 | 518.03 | 10mM | ALK |
T9837 | N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline | 1352608-94-6 | 460.33 | 10mM | ALK |
T15612 | JH-VIII-157-02 | 1639422-97-1 | 465.55 | 10mM | ALK;Microtubule Associated |